Sunrise announces exclusive agreement with Pharmacare for distribution of 6 new drugs in Italy.
We are pleased to announce that Sunrise has entered into an exclusive agreement with Pharmacare for the distribution in Italy of 6 relevant drugs. This agreement allows us to offer healthcare professionals and patients access to cutting-edge therapeutic solutions, with the goal of improving the quality of life and well-being of our community.
The drugs covered by the agreement are as follows and cover several therapeutic areas:
- Pharmacare Alendronate 70 mg
- Amoxicillin and Clavulonic Acid Pharmacare 875+125 mg
- Ciprofloxacin Pharmacare 500 mg
- Ceftriaxone Pharmacare 1 gr/35 ml
- Escitalopram 20 mg/15 ml
- Finasteride 1 mg
The agreement with Pharmacare also represents a major growth opportunity for both companies, facilitating the dissemination of advanced pharmaceutical solutions in a highly competitive market.